Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Yamahaon Jan 21, 2022 9:00am
75 Views
Post# 34341503

RE:RE:RE:Testing, Testing, Testing

RE:RE:RE:Testing, Testing, Testing
Smokey1958 wrote:

Sorry, but you don't know what you're talking about!!! These articles for B.C. in the last 24 hours.

https://www.theglobeandmail.com/canada/article-rapid-tests-to-be-distributed-to-schools-in-british-columbia-2/

https://globalnews.ca/news/8528146/covid-19-growing-demand-in-okanagan-for-rapid-antigen-tests/

https://vancouversun.com/news/local-news/b-c-health-officials-admit-problems-with-covid-rapid-test-deployment

Post again when you've actually done some DD, learned a little biology and don't use vague statements like "many countries". At that point you may finally be taken seriously. In the meantime, Morningstar's Fair Value sp continues to be above $1.00, The NR on the clinical trials should be out no later than the first week of February and the USVstill plans for millions of rapid tests.

Cheers!!!
 


Yamaha wrote:

Smokey1958 wrote:

In spite of the best efforts of many, the pandemic is unlikely to become endemic anytime soon. For that reason alone AcuVid is still in the game. Presuming Rob would not again risk an estimated timeframe misstep there are very few days left in January ...essentially sometime next week for an NR on the final submission to the FDA. The wait and anticipation should finally be over ...let's go THRM!!!

https://globalnews.ca/news/8526416/omicron-herd-immunity-covid/

The Omicron variant, which is spreading far faster than previous versions of the coronavirus, is not likely to help countries achieve so-called herd immunity against COVID-19, in which enough people become immune to the virus that it can no longer spread, leading disease experts say.

https://nationalpost.com/pmn/health-pmn/u-s-preparing-for-possible-future-covid-variants-white-house

“We’re prepared. We’re increasing the production of tests. We’re increasing the production of masks,” Klain said in the interview that was taped on Wednesday.



Sorry but jurisdiction after jurisdiction are dropping most requirements of testing, including BC, the UK, and many other countries, no restrictions no masks normal life with a return to working in a office EUA no longer a priority, no approval will be made. Peel's top doctor asks employers who continue to demand negative tests to 'stop immediately' Chris Fox Chris Fox, CP24 Web Content Writer Published Thursday, January 20, 2022 11:25AM EST




My post clearly showed the source as in yesterday news CP24 and CBC news Not the National Equirer articles you are posting
<< Previous
Bullboard Posts
Next >>